Lucid Diagnostics (LUCD) Intangibles (2022 - 2026)
Lucid Diagnostics (LUCD) posted Intangibles of $210000.0 for Q1 2026, down 33.33% on a QoQ basis from $315000.0 in Q4 2025, and down 66.72% year-over-year from $631000.0 in Q1 2025.
Lucid Diagnostics (LUCD) Intangibles (2022 - 2026) Analysis & Trends
Lucid Diagnostics' Intangibles history runs 5 years deep, the most recent figure standing at $210000.0 for Q1 2026.
- Quarterly Intangibles fell 66.72% year-over-year to $210000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $210000.0 (down 66.72% YoY) and the FY2025 annual result came in at $315000.0, down 57.2% from the prior year.
- Intangibles was $210000.0 for Q1 2026 at Lucid Diagnostics, down from $315000.0 in the prior quarter.
- Across five years, Intangibles topped out at $5.7 million in Q1 2022 and bottomed at $210000.0 in Q1 2026.
- A 5-year average of $2.1 million and a median of $1.1 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles jumped 34.3% — and 2024, when it plunged 84.13%.
- Lucid Diagnostics' Intangibles stood at $3.4 million in 2022, then sank by 58.66% to $1.4 million in 2023, then plunged by 48.31% to $736000.0 in 2024, then tumbled by 57.2% to $315000.0 in 2025, then slumped by 33.33% to $210000.0 in 2026.
- Business Quant data shows LUCD's Intangibles at $210000.0 in Q1 2026, $315000.0 in Q4 2025, and $421000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.88 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 5.52 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 10.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 7.06 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.14 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.91 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 882.00 Mn |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | 210,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210,000.00 |
| Dec 31, 2025 | 315,000.00 |
| Sep 30, 2025 | 421,000.00 |
| Jun 30, 2025 | 526,000.00 |
| Mar 31, 2025 | 631,000.00 |
| Dec 31, 2024 | 736,000.00 |
| Sep 30, 2024 | 842,000.00 |
| Jun 30, 2024 | 947,000.00 |
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 5.31 Mn |
| Jun 30, 2023 | 2.44 Mn |
| Mar 31, 2023 | 2.94 Mn |
| Dec 31, 2022 | 3.45 Mn |
| Sep 30, 2022 | 3.95 Mn |
| Jun 30, 2022 | 4.46 Mn |
| Mar 31, 2022 | 5.71 Mn |